71260	O	O
CT	O	O
CHEST	O	O
w	O	O
CT	O	O
05/06/2007	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
,	O	O
abdomen	O	O
,	O	O
and	O	O
pelvis	O	O
with	O	O
IV	O	O
contrast	O	O
.	O	O
No	O	O
comparison	O	O
.	O	O
Minimally	1_Red_Minutes	O
displaced	1_Red_Minutes	O
fracture	1_Red_Minutes	O
left	1_Red_Minutes	O
scapula	1_Red_Minutes	O
-LRB-	O	O
series	O	O
2	O	O
,	O	O
images	O	O
12-15	O	O
-RRB-	O	O
.	O	O
Mild	O	O
bibasilar	O	O
atelectasis	O	O
.	O	O
Bilateral	O	O
renal	O	O
cysts	O	O
.	O	O
Negative	O	O
liver	O	O
,	O	O
pancreas	O	O
,	O	O
kidneys	O	O
,	O	O
and	O	O
spleen	O	O
with	O	O
no	O	O
evidence	O	O
of	O	O
organ	O	O
injury	O	O
.	O	O
Well	O	O
corticated	O	O
osseus	O	O
density	O	O
anterior	O	O
to	O	O
the	O	3_Yellow_Days
superior	O	3_Yellow_Days
endplate	O	3_Yellow_Days
of	O	3_Yellow_Days
the	O	3_Yellow_Days
T12	O	3_Yellow_Days
vertebral	O	O
body	O	O
,	O	O
likely	O	O
represent	O	O
a	O	O
normal	O	O
variant	O	O
,	O	O
limbus	O	O
vertebrae	O	O
.	O	O
Remainder	O	O
negative	O	O
.	O	O
38078820	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
of	O	O
the	O	O
Thorax	O	O
,	O	O
11/14/2008	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
A	O	O
62-year-old	O	O
male	O	O
with	O	O
history	O	O
of	O	O
supracricoid	O	O
carcinoma	O	O
.	O	O
Findings	O	O
:	O	O
CT	O	O
scan	O	O
of	O	O
the	O	O
chest	O	O
was	O	O
obtained	O	O
after	O	O
the	O	O
administration	O	O
of	O	O
intravenous	O	O
contrast	O	O
.	O	O
No	O	O
prior	O	O
chest	O	O
CTs	O	O
are	O	O
available	O	O
for	O	O
comparison	O	O
.	O	O
Correlation	O	O
is	O	O
made	O	O
with	O	O
the	O	O
previously	O	O
performed	O	O
PET/CTs	O	O
.	O	O
No	O	O
discrete	O	O
pulmonary	O	O
nodules	O	O
are	O	O
identified	O	O
that	O	O
are	O	O
suspicious	O	O
for	O	O
metastatic	O	O
disease	O	O
.	O	O
There	O	O
are	O	O
mediastinal	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
hilar	3_Yellow_Days	3_Yellow_Days
lymph	3_Yellow_Days	3_Yellow_Days
nodes	3_Yellow_Days	3_Yellow_Days
which	3_Yellow_Days	O
are	3_Yellow_Days	O
prominent	3_Yellow_Days	3_Yellow_Days
but	3_Yellow_Days	3_Yellow_Days
stable	3_Yellow_Days	3_Yellow_Days
dating	3_Yellow_Days	O
back	O	O
to	O	O
May	O	O
of	O	O
this	O	O
year	O	O
.	O	O
The	O	O
right	O	O
hilar	O	O
node	O	O
measures	O	O
approximately	O	O
1.8	O	O
x	O	O
2.2	O	O
cm	O	O
.	O	O
A	O	O
mediastinal	O	O
lymph	O	O
node	O	O
measures	O	O
1.1	O	1_Red_Minutes
x	O	1_Red_Minutes
1.1	O	1_Red_Minutes
cm	O	1_Red_Minutes
.	O	O
These	3_Yellow_Days	O
can	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
followed	3_Yellow_Days	3_Yellow_Days
to	3_Yellow_Days	3_Yellow_Days
exclude	3_Yellow_Days	3_Yellow_Days
metastatic	3_Yellow_Days	3_Yellow_Days
disease	3_Yellow_Days	3_Yellow_Days
.	O	O
There	O	O
is	O	O
a	O	O
button	O	O
in	O	O
place	O	O
.	O	O
No	O	O
pleural	O	O
or	O	O
pericardial	O	O
effusion	O	O
is	O	O
seen	O	O
.	O	O
No	O	O
hepatic	O	O
lesions	O	O
are	O	O
identified	O	O
.	O	O
The	O	O
spleen	O	O
contains	O	O
granulomas	O	O
.	O	O
There	O	O
is	O	O
slight	O	O
nodularity	O	O
of	O	O
the	O	O
left	O	O
adrenal	O	O
gland	O	O
.	O	O
IMPRESSION	O	O
:	O	O
No	O	O
definite	O	O
evidence	O	O
of	O	O
metastatic	O	O
disease	O	O
.	O	O
Mediastinal	3_Yellow_Days	O
and	3_Yellow_Days	O
hilar	3_Yellow_Days	O
lymph	3_Yellow_Days	O
nodes	3_Yellow_Days	O
have	3_Yellow_Days	O
remained	3_Yellow_Days	O
stable	3_Yellow_Days	O
dating	O	O
back	O	O
to	O	O
May	O	O
and	O	O
can	O	3_Yellow_Days
be	O	3_Yellow_Days
followed	O	O
on	O	O
subsequent	O	O
exams	O	O
or	O	O
PET/CT	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
71250	O	O
CT	O	O
CHEST	O	O
wo	O	O
CT05/07/2007	O	O
79.330	O	O
</EXAM_CODES>	O	O
<	O	O
REPONonenhanced	O	O
chest	O	O
CT	O	O
with	O	O
reconstructed	O	O
thin	O	O
section	O	O
images	O	O
is	O	O
compared	O	O
to	O	O
CT	O	O
of	O	O
2/19/07	O	O
.	O	O
The	O	O
prominent	3_Yellow_Days	O
precarinal	3_Yellow_Days	O
lymph	3_Yellow_Days	O
node	3_Yellow_Days	O
is	3_Yellow_Days	O
slightly	3_Yellow_Days	O
smaller	3_Yellow_Days	O
today	3_Yellow_Days	O
,	3_Yellow_Days	O
but	3_Yellow_Days	O
remains	3_Yellow_Days	O
larger	3_Yellow_Days	O
than	3_Yellow_Days	O
on	3_Yellow_Days	O
9/12/06	3_Yellow_Days	O
.	O	O
The	O	O
loculated	3_Yellow_Days	O
pleural	3_Yellow_Days	O
fluid	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
left	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
chest	3_Yellow_Days	3_Yellow_Days
posteriorly	3_Yellow_Days	3_Yellow_Days
has	3_Yellow_Days	3_Yellow_Days
decreased	3_Yellow_Days	3_Yellow_Days
slightly	3_Yellow_Days	3_Yellow_Days
in	3_Yellow_Days	3_Yellow_Days
size	3_Yellow_Days	3_Yellow_Days
.	O	O
There	O	O
is	O	O
a	O	O
new	1_Red_Minutes	3_Yellow_Days
pleural	1_Red_Minutes	3_Yellow_Days
or	1_Red_Minutes	3_Yellow_Days
subpleural	1_Red_Minutes	3_Yellow_Days
nodule	1_Red_Minutes	3_Yellow_Days
in	1_Red_Minutes	3_Yellow_Days
the	1_Red_Minutes	3_Yellow_Days
left	1_Red_Minutes	O
lower	1_Red_Minutes	O
chest	1_Red_Minutes	O
posterolaterally	1_Red_Minutes	O
-LRB-	1_Red_Minutes	O
series	1_Red_Minutes	O
2	1_Red_Minutes	O
,	1_Red_Minutes	O
image	1_Red_Minutes	O
42	1_Red_Minutes	O
-RRB-	1_Red_Minutes	O
measuring	1_Red_Minutes	O
approximately	1_Red_Minutes	O
2.1	1_Red_Minutes	O
cm	1_Red_Minutes	O
,	1_Red_Minutes	O
worrisome	1_Red_Minutes	O
for	1_Red_Minutes	O
tumor	1_Red_Minutes	O
.	O	O
Pleural	3_Yellow_Days	O
thickening	3_Yellow_Days	O
elsewhere	3_Yellow_Days	O
in	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
left	3_Yellow_Days	3_Yellow_Days
base	3_Yellow_Days	3_Yellow_Days
has	3_Yellow_Days	3_Yellow_Days
decreased	3_Yellow_Days	3_Yellow_Days
slightly	3_Yellow_Days	3_Yellow_Days
.	O	O
There	O	O
is	O	O
mild	O	3_Yellow_Days
bilateral	O	3_Yellow_Days
gynecomastia	O	3_Yellow_Days
,	O	O
slightly	O	O
more	O	3_Yellow_Days
on	O	3_Yellow_Days
the	O	3_Yellow_Days
right	O	3_Yellow_Days
,	O	O
which	O	O
has	O	O
increased	O	3_Yellow_Days
slightly	O	3_Yellow_Days
.	O	O
Remainder	O	O
unchanged	O	O
.	O	O
PO	O	O
left	O	O
lower	O	O
lobectomy	O	O
.	O	O
Advanced	3_Yellow_Days	O
emphysematous	3_Yellow_Days	O
changes	3_Yellow_Days	O
and	O	O
scattered	O	O
scarring	O	O
bilaterally	O	O
.	O	O
Negative	O	O
adrenal	O	O
glands	O	O
.	O	O
Cardiac	O	O
pacer	O	O
.	O	O
Vascular	O	O
calcifications	O	O
,	O	O
including	O	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
calcifications	3_Yellow_Days	3_Yellow_Days
.	O	O
Left	O	O
renal	O	O
cyst	O	O
.	O	O
MCW	O	O
1816650	O	O
SOB	O	O
CT	O	O
THORAX	O	O
AND	O	O
CT	O	O
PELVIS	O	O
-	O	O
PE	O	O
PROTOCOL	O	O
-LRB-	O	O
#	O	O
836A-B	O	O
-RRB-	O	O
TECHNIQUE	O	O
:	O	O
HELICAL	O	O
CT	O	O
THROUGH	O	O
THE	O	O
THORAX	O	O
AFTER	O	O
ADMINISTRATION	O	O
OF	O	O
CONTRAST	O	O
IS	O	O
PERFORMED	O	O
AND	O	O
REVIEWED	O	O
AS	O	O
CONTIGUOUS	O	O
1.25	O	O
MM	O	O
SLICES	O	O
.	O	O
DELAYED	O	O
LIMITED	O	O
VIEWS	O	O
THROUGH	O	O
THE	O	O
LOWER	O	O
PELVIS	O	O
AND	O	O
LOWER	O	O
EXTREMITIES	O	O
WERE	O	O
ALSO	O	O
PERFORMED	O	O
.	O	O
CORONAL	O	O
AND	O	O
SAGITTAL	O	O
REFORMATS	O	O
ARE	O	O
ALSO	O	O
PROVIDED	O	O
.	O	O
FINDINGS	O	O
:	O	O
NO	O	O
CERVICAL	O	O
OR	O	O
AXILLARY	O	O
LYMPHADENOPATHY	O	O
IS	O	O
SEEN	O	O
.	O	O
THE	O	O
GREAT	O	O
VESSELS	O	O
APPEAR	O	O
NORMAL	O	O
.	O	O
MEDIASTINAL	O	O
LYMPH	O	O
NODES	O	O
ARE	O	O
PROMINENT	O	O
,	O	O
AND	O	O
THERE	O	O
IS	O	O
MILD	3_Yellow_Days	3_Yellow_Days
STRANDING	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
MEDIASTINUM	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
CARDIAC	3_Yellow_Days	O
SIZE	3_Yellow_Days	O
IS	3_Yellow_Days	O
LARGE	3_Yellow_Days	O
.	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
PULMONARY	3_Yellow_Days	3_Yellow_Days
INTERLOBULAR	3_Yellow_Days	3_Yellow_Days
SEPTAL	3_Yellow_Days	3_Yellow_Days
THICKENING	3_Yellow_Days	3_Yellow_Days
IS	O	O
APPRECIATED	O	O
.	O	O
THERE	O	O
IS	O	O
BRONCHIAL	3_Yellow_Days	O
CUFFING	3_Yellow_Days	O
.	O	O
THERE	O	O
IS	O	O
MILD	3_Yellow_Days	3_Yellow_Days
DIFFUSE	3_Yellow_Days	3_Yellow_Days
GROUND-GLASS	3_Yellow_Days	3_Yellow_Days
OPACITY	3_Yellow_Days	3_Yellow_Days
.	O	O
THE	O	O
PULMONARY	1_Red_Minutes	O
VESSELS	1_Red_Minutes	O
ARE	1_Red_Minutes	O
CONGESTED	1_Red_Minutes	O
.	O	O
NO	O	O
PULMONARY	O	O
EMBOLISM	O	O
IS	O	O
IDENTIFIED	O	O
.	O	O
BILATERAL	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
EFFUSIONS	3_Yellow_Days	3_Yellow_Days
ARE	3_Yellow_Days	O
SEEN	O	O
.	O	O
LIMITED	O	O
VIEWS	O	O
THROUGH	O	O
THE	O	O
UPPER	O	O
ABDOMEN	O	O
REVEAL	O	O
SIGNIFICANT	O	O
CONTRAST	O	O
REFLUX	O	O
INTO	O	O
THE	O	O
HEPATIC	O	O
VENOUS	O	O
SYSTEM	O	O
.	O	O
A	O	O
CALCIFIED	O	O
GRANULOMA	O	O
IS	O	O
SEEN	O	O
IN	O	O
THE	O	O
SPLEEN	O	O
.	O	O
NO	O	O
DEEP	O	O
VENOUS	O	O
THROMBOSIS	O	O
IS	O	O
SEEN	O	O
.	O	O
NO	O	O
SIGNIFICANT	O	O
BONY	O	O
ABNORMALITIES	O	O
ARE	O	O
DETECTED	O	O
.	O	O
1	O	O
.	O	O
NO	O	O
PULMONARY	O	O
EMBOLISM	O	O
OR	O	O
DEEP	O	O
VENOUS	O	O
THROMBOSIS	O	O
IDENTIFIED	O	O
.	O	O
2	O	O
.	O	O
CARDIOMEGALY	3_Yellow_Days	3_Yellow_Days
AND	O	3_Yellow_Days
INTERSTITIAL	1_Red_Minutes	3_Yellow_Days
PULMONARY	1_Red_Minutes	3_Yellow_Days
EDEMA	1_Red_Minutes	3_Yellow_Days
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O

